These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6354421)

  • 1. Hyperthermic adjuvant perfusion chemotherapy for Stage I malignant melanoma of the extremity with literature review.
    Rege VB; Leone LA; Soderberg CH; Coleman GV; Robidoux HJ; Fijman R; Brown J
    Cancer; 1983 Dec; 52(11):2033-9. PubMed ID: 6354421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermic perfusion in malignant melanoma: 5-year results.
    Tonak J; Hohenberger W; Weidner F; Göhl H
    Recent Results Cancer Res; 1983; 86():229-38. PubMed ID: 6648004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment and regional chemotherapy in melanoma of the extremities].
    Henneking K; Binder J; Weyers W; Schwemmle K
    Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermic isolation perfusion, wide excision, and regional lymphadenectomy.
    Fletcher JR; White CR; Fletcher WS
    Am J Surg; 1986 May; 151(5):593-8. PubMed ID: 3518512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.
    Schraffordt Koops H; Kroon BB; Oldhoff J; Hoekstra HJ
    World J Surg; 1992; 16(2):241-5. PubMed ID: 1561805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Technique and results of hyperthermic perfusion of the extremity in melanoma patients].
    Omlor G; Bahmer F; Meessen S; Zang D; Feifel G; Zaun H
    Langenbecks Arch Chir; 1993; 378(1):21-5. PubMed ID: 8437498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanomas of the extremities.
    Martijn H; Oldhoff J; Koops HS
    J Surg Oncol; 1982 May; 20(1):9-13. PubMed ID: 7078190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
    Kroon BB; Schraffordt Koops H
    Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of state I melanoma of the extremities with regional hyperthermic isolation perfusion.
    Janoff KA; Moseson D; Nohlgren J; Davenport C; Richards C; Fletcher WS
    Ann Surg; 1982 Sep; 196(3):316-23. PubMed ID: 7114937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity].
    Huber R; Krüger I; Stützer H
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():118-21. PubMed ID: 9101808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermic perfusion of recurrent malignant melanoma on the extremities.
    Hafström L; Jönsson PE
    Acta Chir Scand; 1980; 146(5):313-8. PubMed ID: 7468061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.
    Vrouenraets BC; Kroon BB; Klaase JM; Van Geel BN; Eggermont AM; Franklin HR
    J Surg Oncol; 1993 Apr; 52(4):249-54. PubMed ID: 8468989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical results of extremity perfusion in malignant melanoma].
    Huber R; Stützer H; Krüger I
    Zentralbl Chir; 1996; 121(3):234-42. PubMed ID: 8867351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfusion therapy for extremity melanoma.
    Brown AS; Wallack MK; Horstmann JT; Hamilton RW; Johnson JL; Rosato FE
    Arch Surg; 1976 Sep; 111(9):961-3. PubMed ID: 949257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry of cytostatics in hyperthermic regional isolated perfusion.
    van Os J; Schraffordt Koops H; Oldhoff J
    Cancer; 1985 Feb; 55(4):698-701. PubMed ID: 3967166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional chemotherapy for melanoma. A 35-year experience.
    Krementz ET; Carter RD; Sutherland CM; Muchmore JH; Ryan RF; Creech O
    Ann Surg; 1994 Oct; 220(4):520-34; discussion 534-5. PubMed ID: 7944662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival of patients with stage II melanoma of the extremity using hyperthermic isolation perfusion with 1-phenylalanine mustard.
    Hartley JW; Fletcher WS
    J Surg Oncol; 1987 Nov; 36(3):170-4. PubMed ID: 3682836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
    Binder J; Henneking K
    Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regional hyperthermic perfusion with cytostatic agents in malignant melanoma of the extremities (author's transl)].
    Ghussen F; Nagel K; Groth W
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1612-5. PubMed ID: 7308000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extremity perfusion in malignant melanoma].
    Hohenberger W; Meyer T; Göhl J
    Chirurg; 1994 Mar; 65(3):175-85. PubMed ID: 8194401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.